购物车
全部删除
您的购物车当前为空
别名 Labetuzumab-SN38, IMMU-130, IMMU130, IMMU 130, hMN14-SN38
Labetuzumab govitecan is an anti-CEACAM5/SN-38 antibody-drug conjugate for therapy of refractory or relapsing metastatic colorectal cancer.
Labetuzumab govitecan is an anti-CEACAM5/SN-38 antibody-drug conjugate for therapy of refractory or relapsing metastatic colorectal cancer.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 12,000 | 待询 | |
| 5 mg | 待询 | 待询 |
| 产品描述 | Labetuzumab govitecan is an anti-CEACAM5/SN-38 antibody-drug conjugate for therapy of refractory or relapsing metastatic colorectal cancer. |
| 别名 | Labetuzumab-SN38, IMMU-130, IMMU130, IMMU 130, hMN14-SN38 |
| 反应种属 | Human |
| 应用 | ELISA FCM Functional assay |
| 抗体种类 | Monoclonal |
| 内毒素 | < 1.0 EU/mg |
| Uniprot ID | |
| 靶点 | CEACAM5/SN-38 |
| CAS No. | 1469876-18-3 |
| 密度 | no data available |
| 同型 | IgG1 |
| 存储 | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多